Monsanto develops product to deactivate controversial farm chemical
CHICAGO (Reuters) - Monsanto Co is launching the first product that deactivates a controversial weed killer inside spraying equipment after it is used, the company said on Tuesday, its latest attempt to prevent unintended crop damage associated with the herbicide.
UPDATE 1-Amazon boss Bezos supports scrutiny of big companies
BERLIN, April 24 (Reuters) - Amazon Chief Executive Jeff Bezos said on Tuesday that it was right that big companies are scrutinized and said his firm would respond to any new regulations by finding new ways to please its customers.
AstraZeneca flop a fresh blow to cancer immunotherapy combination
LONDON (Reuters) - The concept of combining two immunotherapy drugs to fight lung cancer - not so long ago one of the hottest ideas in cancer research - has suffered a fresh blow from the failure of an AstraZeneca
Ex-Roche scientist Reed to head Sanofi R&D as Zerhouni retires
(Reuters) - Sanofi said on Tuesday it had hired former Roche top scientist John Reed to head its research operations from July 1, when Elias Zerhouni retires from the French drugmaker.
China keeps fuel exports to North Korea low in March as sanctions bite
BEIJING, April 24 (Reuters) - China kept fuel exports to North Korea to a trickle in March and exported no corn for a third straight month to its isolated neighbor, data showed on Tuesday, as sanctions over Pyongyang's nuclear weapons and missile program continued to bite.
China says U.S. Section 301 probe does not objectively view China's progress in IP protection
BEIJING, April 24 (Reuters) - The U.S. intellectual property probe conducted under Section 301 of the Trade Act does not objectively view China's progress in the protection of intellectual property, Shen Changyu, head of China's State Intellectual Property Office, said on Tuesday.
Monkey in 'selfie' cannot sue for copyright, U.S. court says
(Reuters) - Monkeys lack standing to sue for copyright protection and an animal rights group cannot act as legal guardian in such matters, a U.S. appeals court ruled on Monday, in a battle over ownership of a smiling "selfie" taken by an endangered macaque.
Gender bias in peer review of research grants may penalize women
(Reuters Health) - Female researchers may be less successful at winning grant funding than their male counterparts with similar experience and qualifications at least in part because of gender bias among reviewers, a Canadian study suggests.
Angola satellite inoperative, Russia to build another one
LUANDA (Reuters) - Russia's space agency said on Monday that Angola's first national telecoms satellite, AngoSat-1, was inoperative and Russia would build another one for launch in 2020.
FDA declines to approve Pfizer biosimilar of Roche's cancer drug
(Reuters) - Pfizer Inc said on Monday U.S. regulators declined to approve the company's biosimilar of Roche's blockbuster treatment for breast cancer, Herceptin, and sought additional technical information.
- More Science Headlines»